BM
Brett P Monia
Chief Executive OfficerDirector

Brett P Monia insider trades: Ionis Pharmaceuticals (IONS) stock sales

Chief Executive Officer, Ionis Pharmaceuticals Last trade May 14, 2026 98 Form 4 filings
$11.4M
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
62
Open-market trades
since 2012
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brett reports to the SEC

Open-market buys and sales

62 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 14, 2026IONS↓ Sell10b5-1$356K
Feb 6, 2026IONS↓ Sell10b5-1$2.5M
Jan 30, 2026IONS↓ Sell$5.2M
Jan 16, 2026IONS↓ Sell$3.3M
Oct 6, 2025IONS↓ Sell10b5-1$30K
Sep 3, 2025IONS↓ Sell10b5-1$12.3M
Jul 30, 2025IONS↓ Sell10b5-1$109K
Jul 11, 2025IONS↓ Sell10b5-1$48K
Mar 11, 2025IONS↓ Sell10b5-1$5K
Feb 4, 2025IONS↓ Sell10b5-1$1.2M
Jan 31, 2025IONS↓ Sell$430K
Jan 16, 2025IONS↓ Sell$1.1M
Nov 12, 2024IONS↓ Sell10b5-1$252K
Feb 16, 2024IONS↓ Sell$17K
Feb 2, 2024IONS↓ Sell$1.2M
Jan 25, 2024IONS↓ Sell$118K
Jan 17, 2024IONS↓ Sell$1.6M
Dec 21, 2023IONS↓ Sell$1.2M
Dec 14, 2023IONS↓ Sell$1.2M
Oct 12, 2023IONS↓ Sell10b5-1$173K
Jul 7, 2023IONS↓ Sell10b5-1$788K
May 22, 2023IONS↓ Sell10b5-1$198K
Feb 6, 2023IONS↓ Sell$1.0M
Jan 18, 2023IONS↓ Sell$990K
Apr 1, 2022IONS↓ Sell10b5-1$13K
Mar 1, 2021IONS↓ Sell10b5-1$13K
Dec 4, 2020IONS↓ Sell10b5-1$1.2M
Dec 2, 2020IONS↓ Sell10b5-1$1.1M
Sep 1, 2020IONS↓ Sell10b5-1$17K
Jan 2, 2020IONS↓ Sell10b5-1$10K
Nov 20, 2019IONS↓ Sell10b5-1$347K
Jul 2, 2019IONS↓ Sell10b5-1$14K
Jan 2, 2019IONS↓ Sell10b5-1$11K
Nov 23, 2018IONIS↓ Sell10b5-1$1.9M
Aug 27, 2018IONS↓ Sell10b5-1$891K
Jul 24, 2018IONS↓ Sell10b5-1$7K
Jan 16, 2018IONS↓ Sell$146K
Jan 2, 2018IONS↓ Sell10b5-1$8K
Jul 3, 2017IONS↓ Sell10b5-1$16K
Jan 17, 2017IONS↓ Sell$116K
Jan 3, 2017IONS↓ Sell10b5-1$15K
Dec 20, 2016IONS↓ Sell10b5-1$7K
Jan 19, 2016IONS↓ Sell$92K
Jan 4, 2016IONS↓ Sell10b5-1$8K
Jul 2, 2015ISIS↓ Sell10b5-1$11K
Jun 8, 2015ISIS↓ Sell10b5-1$503K
Jan 16, 2015ISIS↓ Sell$104K
Jan 2, 2015ISIS↓ Sell10b5-1$5K
Aug 26, 2014ISIS↓ Sell10b5-1$1.0M
Jul 31, 2014ISIS↓ Sell10b5-1$2K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IONS insiders

Open-market trades in the last 12 months

About Brett P Monia's insider trades

Brett P Monia is Chief Executive Officer at Ionis Pharmaceuticals (IONS). Since Jul 3, 2012, Brett has reported no open-market purchases and 62 sales worth $46.5M on SEC Form 4. In the last 12 months: 4 sales ($11.4M).

44 sales (62% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (40 filings), option exercises (30 filings), other transactions (28 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IONS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.